The market may have overreacted here. The post Where to from here for Cochlear shares? appeared first on The Motley Fool Australia.

Cochlear's HY26 saw profit decline and steady dividends, as Nexa implant rollout supports second-half growth plans. The post Cochlear posts modest sales growth but lower profit as Nexa launch ...

The Australian sharemarket saw a dip on Friday, February 13, 2026, but concluded its best week in ten months. Strong company earnings, especially from banks, propelled the benchmark towards record ...

Precise electrical stimulation is essential for modern neural interfaces, but unwanted current spread often activates off-target cells and limits resolution. A new microneedle electrode design ...

Cochlear Limited (ASX: COH), a global leader in implantable hearing solutions, today announced its financial results for the ...

As well as being touched by the sweetness of the stories, anyone ignorant about deafness will get an education ...

Today we will run through one way of estimating the intrinsic value of Cochlear Limited (ASX:COH) by estimating the company's future cash flows and discounting them to their present value. We will use ...

Cochlear expects full-year earnings to be at the lower end of guidance, and has written down the value of its investment in Saluda.

A new study examining music habits among cochlear implant users has found that better hearing ability with the implant—as measured by standard speech tests—significantly correlates with increased time ...

Impeccable Cantonese cooking is on show at the Club Rivers restaurant.

Explore Cochlear's strategies for managing revenue and margins as it prepares to release its HY 2026 earnings.

Underlying net profit for the December half fell 10% in constant currency terms to A$194.8 million. Cochlear said it expects full-year underlying net profit at the lower end of its previously issued ...